Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

NTLAIntellia Therapeutics, Inc.

Nasdaq · CIK 0001652130
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2835 In Vitro & In Vivo Diagnostic Substances
FY end1231
XBRL facts287

Identity from submissions API

NameIntellia Therapeutics, Inc.
CIK0001652130
TickersNTLA
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2835 In Vitro & In Vivo Diagnostic Substances
EIN364785571
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone857-285-6200
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
400 TECHNOLOGY SQUARE
SUITE 100
CAMBRIDGE
MA
MA
Mailing address
400 TECHNOLOGY SQUARE
SUITE 100
CAMBRIDGE
MA
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

727 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 S-3ASR S-3ASR 0001193125-26-470525 333-300200 261580197 33 1688672 1 1
2026-11-13 8-K/A 8-K/A 7.01,9.01 0001193125-26-460948 001-37766 261553875 34 29404713 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458422 001-37766 261547118 34 29399464 1 1
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000674 005-89486 261538078 34 8054
2026-11-05 10-Q 10-Q 0001193125-26-449862 001-37766 261527559 34 12436440 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001193125-26-448673 001-37766 261524957 34 399746 1 1
2026-11-03 4 4 0001193125-26-445417 6185
2026-11-02 144 xsl144X01/primary_doc.xml 0001969223-26-001116 001-37766 261512530 33 5834
2026-10-28 4 4 0001193125-26-436131 7138
2026-10-28 3 3 0001193125-26-436123 15500
2026-10-06 4 4 0001193125-26-415541 4932
2026-10-05 144 xsl144X01/primary_doc.xml 0001950047-26-010054 001-37766 261441035 33 5401
2026-09-08 8-K 8-K 7.01,8.01,9.01 0001193125-26-385194 001-37766 261365084 34 257989 1 1
2026-09-04 8-K 8-K 1.01,2.03,7.01,9.01 0001193125-26-383645 001-37766 261362180 34 236207 1 1
2026-08-24 4 4 0001193125-26-363567 7609
2026-08-20 144 xsl144X01/primary_doc.xml 0001969223-26-000938 001-37766 261299881 33 5112
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000484 005-89486 261251949 34 8099
2026-08-06 10-Q 10-Q 0001193125-26-337952 001-37766 261248877 34 9898623 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-336772 001-37766 261246064 34 407114 1 1
2026-07-24 4 4 0001193125-26-316279 5412
2026-07-06 4 4 0002019493-26-000002 5400
2026-07-06 4 4 0001821530-26-000002 4845
2026-07-02 144 xsl144X01/primary_doc.xml 0001950047-26-006836 001-37766 261152006 33 4789
2026-06-15 8-K 8-K 7.01,8.01,9.01 0001193125-26-270358 001-37766 261089162 34 291414 1 1
2026-06-10 4 4 0001545794-26-000001 7095
2026-06-10 4 4 0001193125-26-266241 7065
2026-06-10 4 4 0001756929-26-000002 7114
2026-06-10 4 4 0001193125-26-266236 7097
2026-06-10 4 4 0001193125-26-266233 7083
2026-06-10 4 4 0001563572-26-000001 7065
2026-06-10 4 4 0001193125-26-266230 7115
2026-06-10 8-K 8-K 5.07 0001193125-26-265934 001-37766 261080197 34 212644 1 1
2026-05-11 10-Q 10-Q 0001193125-26-215740 001-37766 26960908 34 9040482 1 1
2026-05-11 8-K 8-K 2.02,9.01 0001193125-26-215721 001-37766 26960891 34 346407 1 1
2026-04-30 8-K 8-K 1.01,2.02,9.01 0001193125-26-197489 001-37766 26926121 34 401031 1 1
2026-04-30 ARS ARS 0001193125-26-197422 001-37766 26925885 34 1104475
2026-04-30 DEFA14A DEFA14A 0001193125-26-197355 001-37766 26925651 34 5462671
2026-04-30 DEF 14A DEF 14A 0001193125-26-197283 001-37766 26925383 34 4512693 1 1
2026-04-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000581 005-89486 26920997 34 7410
2026-04-29 424B5 424B5 0001193125-26-192361 333-275740 26918237 33 740828 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000395 005-89486 26913688 34 7353
2026-04-27 424B5 424B5 0001193125-26-182419 333-275740 26902147 33 605215
2026-04-27 8-K 8-K 7.01,8.01,9.01 0001193125-26-179401 001-37766 26896891 34 6165528 1 1
2026-04-10 8-K 8-K 5.03,9.01 0001193125-26-151300 001-37766 26855081 34 285202 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001517 005-89486 26801630 34 7175
2026-03-03 4 4 0001193125-26-088269 7890
2026-03-03 4 4 0001193125-26-088260 8646
2026-03-03 4 4 0001193125-26-088258 6982
2026-03-03 4 4 0001193125-26-088254 6996
2026-03-03 4 4 0001193125-26-088251 6994
2026-03-03 4 4 0001193125-26-088241 8673
2026-03-03 4 4 0001193125-26-088236 4684
2026-03-02 424B5 424B5 0001193125-26-085425 333-275740 26707735 33 832657 1 1
2026-03-02 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-26-084309 001-37766 26703583 34 234637 1 1
2026-02-26 S-8 S-8 0001193125-26-077385 333-293823 26690704 33 176903 1 1
2026-02-26 10-K 10-K 0001193125-26-076550 001-37766 26687833 34 16714922 1 1
2026-02-26 8-K 8-K 2.02,9.01 0001193125-26-073456 001-37766 26681740 34 388501 1 1
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000886982-26-000085 005-89486 26625521 34 18294
2026-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001999371-26-003032 005-89486 26619707 34 9581
2026-02-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-26-000056 005-89486 26609548 34 7991
2026-02-03 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-009584 005-89486 26590925 34 14892
2026-01-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000156 005-89486 26582308 34 7018
2026-01-27 8-K 8-K 7.01,8.01,9.01 0001193125-26-023387 001-37766 26562095 34 189175 1 1
2026-01-09 8-K 8-K 7.01,8.01,9.01 0001193125-26-008307 001-37766 26521383 34 5101715 1 1
2026-01-07 4 4 0001193125-26-006294 5687
2026-01-07 4 4 0001193125-26-006292 5035
2026-01-07 4 4 0001193125-26-006291 17669
2026-01-07 4 4 0001193125-26-006288 5071
2026-01-07 4 4 0001193125-26-006283 5030
2026-01-07 4 4 0001193125-26-006278 4986
2026-01-07 4 4 0001193125-26-006275 4795
2026-01-07 4 4 0001193125-26-006264 4786
2025-12-12 4 4 0001193125-25-317551 16867
2025-12-11 144 xsl144X01/primary_doc.xml 0001969223-25-001077 001-37766 251565105 33 5636
2025-11-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000886982-25-001471 005-89486 251472317 34 16900
2025-11-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001999371-25-017496 005-89486 251471472 34 9734
2025-11-10 8-K 8-K 7.01,8.01,9.01 0001193125-25-274596 001-37766 251467468 34 238874 1 1
2025-11-06 10-Q 10-Q 0001193125-25-269680 001-37766 251458821 34 10747995 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-269479 001-37766 251458227 34 225042 1 1
2025-11-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-106358 005-89486 251450276 34 15182
2025-10-29 8-K 8-K 8.01 0001193125-25-256378 001-37766 251430303 34 143746 1 1
2025-10-27 8-K 8-K 7.01,8.01,9.01 0001193125-25-250757 001-37766 251417523 34 221158 1 1
2025-10-03 4 4 0001193125-25-230424 16187
2025-10-03 4 4 0001193125-25-230420 4788
2025-09-25 8-K 8-K 7.01,8.01,9.01 0001193125-25-217484 001-37766 251343994 34 211307 1 1
2025-08-22 4 4 0000950170-25-110979 5059
2025-08-07 10-Q 10-Q 0000950170-25-104987 001-37766 251193913 34 10612319 1 1
2025-08-07 8-K 8-K 2.02,5.02,9.01 0000950170-25-104574 001-37766 251191661 34 405696 1 1
2025-07-25 4 4 0000950170-25-098774 4796
2025-07-03 4 4 0000950170-25-093852 4664
2025-07-03 4 4 0000950170-25-093844 4784
2025-07-02 4 4 0000950170-25-093302 6026
2025-06-18 4 4 0000950170-25-087887 17311
2025-06-16 8-K 8-K 7.01,8.01,9.01 0001193125-25-141087 001-37766 251048511 34 193961 1 1
2025-06-13 4 4 0000950170-25-086287 17326
2025-06-13 4 4 0000950170-25-086277 17342
2025-06-13 4 4 0000950170-25-086271 17322
2025-06-13 4 4 0000950170-25-086243 17343
2025-06-13 4 4 0000950170-25-086231 17308
2025-06-13 4 4 0000950170-25-086223 17312
2025-06-12 8-K 8-K 5.02,5.07,9.01 0000950170-25-085479 001-37766 251043299 34 263997 1 1
2025-06-11 S-8 S-8 0001193125-25-139258 333-287959 251040849 33 301873 1 1
2025-05-28 8-K 8-K 7.01,8.01 0001193125-25-129524 001-37766 25995956 34 140424 1 1
2025-05-19 8-K 8-K 7.01,8.01,9.01 0001193125-25-122076 001-37766 25961436 34 246768 1 1
2025-05-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-25-000280 005-89486 25938104 34 8045
2025-05-08 10-Q 10-Q 0000950170-25-066914 001-37766 25925942 34 9187995 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066403 001-37766 25923940 34 357550 1 1
2025-05-01 4 4 0000950170-25-061881 4622
2025-04-30 ARS ARS 0001193125-25-107340 001-37766 25895733 34 1151738
2025-04-30 DEFA14A DEFA14A 0000950170-25-061058 001-37766 25895318 34 4644171
2025-04-30 DEF 14A DEF 14A 0000950170-25-061023 001-37766 25894878 34 8792160 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000614 005-89486 25844581 34 11055
2025-04-07 8-K 8-K 5.03,9.01 0001193125-25-073904 001-37766 25816263 34 289917 1 1
2025-03-04 4 4 0000950170-25-032263 8680
2025-03-04 4 4 0000950170-25-032248 7897
2025-03-04 4 4 0000950170-25-032192 7003
2025-03-04 4 4 0000950170-25-032141 4691
2025-03-04 4 4 0000950170-25-032125 6990
2025-03-04 4 4 0000950170-25-032101 7001
2025-03-04 4 4 0000950170-25-032086 8652
2025-02-28 S-8 S-8 0001193125-25-042458 333-285414 25689895 33 232355 1 1
2025-02-27 10-K 10-K 0000950170-25-029007 001-37766 25678591 34 16614673 1 1
2025-02-27 8-K 8-K 2.02,9.01 0000950170-25-028373 001-37766 25673071 34 398369 1 1
2025-02-21 8-K 8-K 1.01,2.03 0001193125-25-031989 001-37766 25651721 34 149290 1 1
2025-01-31 4 4 0000950170-25-011757 4630
2025-01-23 3 3 0000950170-25-008426 24950
2025-01-10 8-K 8-K 2.02,2.05,5.02,7.01,8.01,9.01 0001193125-25-004080 001-37766 25520419 34 246702 1 1
2025-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000028 005-89486 25517188 34 6272
2025-01-07 4 4 0000950170-25-003032 14384
2025-01-07 4 4 0000950170-25-003028 4760
2025-01-07 4 4 0000950170-25-003015 4790
2025-01-07 4 4 0000950170-25-003014 14395
2025-01-07 4 4 0000950170-25-003012 5694
2025-01-07 4 4 0000950170-25-003002 4807
2025-01-06 4 4 0000950170-25-002115 15958
2025-01-03 4 4 0000950170-25-001237 17350
2025-01-03 4 4 0000950170-25-001236 18010
2025-01-03 4 4 0000950170-25-001232 17381
2024-11-18 8-K 8-K 7.01,8.01,9.01 0001193125-24-260417 001-37766 241469737 34 272708 1 1
2024-11-07 10-Q 10-Q 0000950170-24-123276 001-37766 241435511 34 8472357 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-122810 001-37766 241433236 34 345102 1 1
2024-10-25 8-K 8-K 7.01,8.01,9.01 0001193125-24-244201 001-37766 241397706 34 210688 1 1
2024-10-04 4 4 0000950170-24-112980 5280
2024-08-08 10-Q 10-Q 0000950170-24-093907 001-37766 241188208 34 8527312 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093339 001-37766 241186101 34 349646 1 1
2024-07-24 4 4 0000950170-24-086061 7008
2024-07-24 3 3 0000950170-24-086046 11721
2024-07-18 S-8 S-8 0001193125-24-181015 333-280878 241124784 33 75928
2024-07-03 4 4 0000950170-24-081259 4669
2024-07-03 4 4 0000950170-24-081258 4694
2024-06-26 8-K 8-K 5.02,7.01,9.01 0001193125-24-168545 001-37766 241070663 34 522089 1 1
2024-06-20 4 4 0000950170-24-075718 4610
2024-06-17 3 3 0000950170-24-074387 13030
2024-06-17 4 4 0000950170-24-074383 7033
2024-06-14 8-K 8-K 5.02,7.01,9.01 0000950170-24-073709 001-37766 241045206 34 203606 1 1
2024-06-14 4 4 0000950170-24-073704 6966
2024-06-14 4 4 0000950170-24-073702 6972
2024-06-14 4 4 0000950170-24-073700 6985
2024-06-14 4 4 0000950170-24-073689 6957
2024-06-14 4 4 0000950170-24-073685 6986
2024-06-14 4 4 0000950170-24-073680 6938
2024-06-13 8-K 8-K 5.03,5.07,9.01 0000950170-24-073116 001-37766 241042008 34 236131 1 1
2024-05-09 10-Q 10-Q 0000950170-24-057046 001-37766 24931130 34 7594710 1 1
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056286 001-37766 24928612 34 312285 1 1
2024-04-29 ARS ARS 0001193125-24-122499 001-37766 24891548 34 1233835
2024-04-29 DEFA14A DEFA14A 0000950170-24-049909 001-37766 24891289 34 5645350
2024-04-29 DEF 14A DEF 14A 0000950170-24-049875 001-37766 24891011 34 4327088 1 1
2024-04-22 3 3 0000950170-24-046423 13954
2024-04-16 PRE 14A PRE 14A 0000950170-24-044774 001-37766 24847916 34 4338660 1 1
2024-04-15 8-K 8-K 5.02 0000950170-24-044424 001-37766 24844902 34 195968 1 1
2024-03-22 8-K 8-K 1.02 0001193125-24-074706 001-37766 24773392 34 151055 1 1
2024-03-05 4 4 0000950170-24-025907 7006
2024-03-05 4 4 0000950170-24-025906 8652
2024-03-05 4 4 0000950170-24-025903 6985
2024-03-05 4 4 0000950170-24-025902 8681
2024-03-05 4 4 0000950170-24-025900 7896
2024-03-05 4 4 0000950170-24-025904 6989
2024-03-05 4 4 0000950170-24-025901 7048
2024-02-26 424B5 424B5 0001193125-24-045305 333-275740 24673515 33 625330
2024-02-23 424B5 424B5 0001193125-24-044711 333-275740 24672688 33 577891
2024-02-23 8-K 8-K 1.01,9.01 0001193125-24-044690 001-37766 24672619 34 186587 1 1
2024-02-22 S-8 S-8 0001193125-24-042829 333-277266 24664847 33 56658
2024-02-22 10-K 10-K 0000950170-24-018736 001-37766 24664614 34 13146262 1 1
2024-02-22 8-K 8-K 2.02,9.01 0000950170-24-018436 001-37766 24662340 34 343659 1 1
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021209 005-89486 24628748 34 13072
2024-02-01 8-K 8-K 7.01,9.01 0000950170-24-009776 001-37766 24586888 34 208792 1 1
2024-01-29 SC 13G/A SC 13G/A 0001104659-24-007686 005-89486 24573546 34 44772
2024-01-24 SC 13G/A Intellia_Therap.txt 0000093751-24-000152 005-89486 24555109 34 8537
2024-01-10 4 4 0000950170-24-003632 7081
2024-01-08 SC 13G/A us45826j1051_010824.txt 0001086364-24-000149 005-89486 24520610 34 13722
2024-01-08 144 xsl144X01/primary_doc.xml 0001973141-24-000021 001-37766 24520058 33 4457
2024-01-05 4 4 0000950170-24-002516 5694
2024-01-05 4 4 0000950170-24-002515 4790
2024-01-05 4 4 0000950170-24-002514 4807
2024-01-05 4 4 0000950170-24-002511 4791
2024-01-05 4 4 0000950170-24-002507 4800
2024-01-05 4 4 0000950170-24-002504 4760
2024-01-05 4 4 0000950170-24-002502 6363
2024-01-04 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-24-002438 001-37766 24511861 34 230717 1 1
2024-01-03 4 4 0000950170-24-001210 7396
2024-01-03 4 4 0000950170-24-001204 7379
2024-01-03 4 4 0000950170-24-001197 8041
2024-01-03 4 4 0000950170-24-001173 7138
2023-12-07 144 xsl144X01/primary_doc.xml 0000950170-23-068894 001-37766 231473738 33 5050
2023-12-06 8-K 8-K 5.02 0001193125-23-289530 001-37766 231468396 34 142790 1 1
2023-11-24 S-3ASR S-3ASR 0001193125-23-282618 333-275740 231435268 33 1220303
2023-11-09 10-Q 10-Q 0000950170-23-062011 001-37766 231392285 34 12425115 1 1
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-061539 001-37766 231390107 34 396947 1 1
2023-11-02 4 FORM 4 SUBMISSION 0001209191-23-054163 4774
2023-11-02 8-K 8-K 7.01,8.01,9.01 0001193125-23-268816 001-37766 231370044 34 7110798 1 1
2023-10-18 8-K 8-K 7.01,8.01,9.01 0001193125-23-258063 001-37766 231330924 34 219613 1 1
2023-10-03 8-K 8-K 7.01,8.01,9.01 0001193125-23-249487 001-37766 231301550 34 218476 1 1
2023-08-03 10-Q 10-Q 0000950170-23-037996 001-37766 231140159 34 12666172 1 1
2023-08-03 8-K 8-K 2.02,9.01 0000950170-23-037597 001-37766 231138115 34 448097 1 1
2023-08-02 4 FORM 4 SUBMISSION 0001209191-23-044257 4774
2023-07-31 144 xsl144X01/primary_doc.xml 0001950047-23-002612 001-37766 231127948 33 5315
2023-07-10 4 FORM 4 SUBMISSION 0001209191-23-041951 5255
2023-07-06 144 xsl144X01/primary_doc.xml 0001950047-23-002162 001-37766 231073874 33 5209
2023-07-06 4 FORM 4 SUBMISSION 0001209191-23-041495 5295
2023-06-22 4 FORM 4 SUBMISSION 0001209191-23-039148 8811
2023-06-20 144 xsl144X01/primary_doc.xml 0001950047-23-001815 001-37766 231027058 33 4617
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037910 7243
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037898 7268
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037892 7274
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037889 7287
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037879 7280
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037873 7259
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037860 7288
2023-06-16 8-K 8-K 5.03,5.07,9.01 0000950170-23-028611 001-37766 231021241 34 274554 1 1
2023-06-12 8-K 8-K 7.01,8.01,9.01 0001193125-23-164890 001-37766 231007069 34 238988 1 1
2023-06-05 DEFA14A DEFA14A 0001193125-23-160821 001-37766 23993805 34 51034
2023-06-05 8-K 8-K 5.02,7.01,9.01 0001193125-23-160779 001-37766 23993388 34 175495 1 1
2023-05-04 10-Q 10-Q 0000950170-23-017866 001-37766 23888858 34 10406255 1 1
2023-05-04 8-K 8-K 2.02,9.01 0000950170-23-017472 001-37766 23886537 34 401283 1 1
2023-05-01 DEFA14A DEFA14A 0000950170-23-016273 001-37766 23874127 34 4264201
2023-05-01 DEF 14A DEF 14A 0000950170-23-016262 001-37766 23873993 34 6029927 1 1
2023-04-18 4 FORM 4 SUBMISSION 0000899243-23-011381 7309
2023-04-18 3 FORM 3 SUBMISSION 0000899243-23-011380 7687
2023-04-18 ARS ARS 0001193125-23-105031 001-37766 23827122 34 12982968
2023-04-18 PRE 14A PRE 14A 0000950170-23-013281 001-37766 23827038 34 5926970 1 1
2023-04-17 8-K 8-K 5.02,7.01,9.01 0001193125-23-103787 001-37766 23824583 34 180718 1 1
2023-03-24 8-K 8-K 5.02 0001193125-23-078511 001-37766 23757627 34 142530 1 1
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015817 7255
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015776 7267
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015764 8173
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015753 7266
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015742 7283
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015732 8816
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015722 10530
2023-03-02 8-K 8-K 8.01,9.01 0001193125-23-057278 001-37766 23696423 34 178692 1 1
2023-02-23 S-8 S-8 0001193125-23-046579 333-269947 23659879 33 56523
2023-02-23 10-K 10-K 0000950170-23-004097 001-37766 23659664 34 17298594 1 1
2023-02-23 8-K 8-K 2.02,9.01 0000950170-23-003940 001-37766 23655968 34 452861 1 1
2023-02-10 SC 13G/A SC 13G/A 0001104659-23-018264 005-89486 23609960 34 42345
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016212 005-89486 23603503 34 12992
2023-02-09 SC 13G/A filing.txt 0000315066-23-001774 005-89486 23603026 34 8230
2023-01-25 SC 13G us45826j1051_012523.txt 0001306550-23-003411 005-89486 23550534 34 13425
2023-01-06 4 FORM 4 SUBMISSION 0001209191-23-002433 9087
2023-01-06 4 FORM 4 SUBMISSION 0001209191-23-002425 5690
2023-01-06 4 FORM 4 SUBMISSION 0001209191-23-002421 4771
2023-01-06 4 FORM 4 SUBMISSION 0001209191-23-002417 4786
2023-01-06 4 FORM 4 SUBMISSION 0001209191-23-002414 4787
2023-01-06 4 FORM 4 SUBMISSION 0001209191-23-002412 8231
2023-01-06 4 FORM 4 SUBMISSION 0001209191-23-002410 4756
2023-01-05 8-K 8-K 2.02,7.01,8.01,9.01 0000950170-23-000179 001-37766 23509734 34 268725 1 1
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001498 7708
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001495 8354
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001492 7691
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001490 7450
2022-12-01 8-K 8-K 1.01,9.01 0001193125-22-296686 001-37766 221439688 34 383153 1 1
2022-12-01 424B5 424B5 0001193125-22-296651 333-251022 221439517 33 540377
2022-11-14 8-K 8-K 7.01,8.01,9.01 0000950170-22-024693 001-37766 221380268 34 299629 1 1
2022-11-07 8-K 8-K 7.01,8.01,9.01 0000950170-22-022671 001-37766 221366084 34 282049 1 1
2022-11-03 10-Q 10-Q 0000950170-22-021835 001-37766 221357855 34 13746369 1 1
2022-11-03 8-K 8-K 2.02,9.01 0000950170-22-021559 001-37766 221356269 34 457976 1 1
2022-09-16 8-K 8-K 7.01,8.01,9.01 0001193125-22-246030 001-37766 221246974 34 307583 1 1
2022-08-04 10-Q 10-Q 0000950170-22-014731 001-37766 221136423 34 12245168 1 1
2022-08-04 8-K 8-K 2.02,9.01 0000950170-22-014480 001-37766 221134744 34 439442 1 1
2022-06-24 8-K 8-K 8.01,9.01 0001193125-22-180763 001-37766 221036971 34 221611 1 1
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037604 11201
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037602 11224
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037600 11221
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037598 7887
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037595 11190
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037592 7247
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037590 11208
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037588 7244
2022-06-15 8-K 8-K 5.07 0000950170-22-011691 001-37766 221018417 34 227202 1 1
2022-05-05 10-Q 10-Q 0000950170-22-007805 001-37766 22896186 34 12178769 1 1
2022-05-05 8-K 8-K 2.02,9.01 0000950170-22-007567 001-37766 22894114 34 399354 1 1
2022-05-03 8-K 8-K 5.02 0001193125-22-137551 001-37766 22884544 34 148727 1 1
2022-05-02 4 FORM 4 SUBMISSION 0001209191-22-026561 7320
2022-05-02 3 FORM 3 SUBMISSION 0001209191-22-026560 6832
2022-05-02 DEFA14A DEFA14A 0000950170-22-006884 001-37766 22882533 34 244944
2022-05-02 DEF 14A DEF 14A 0000950170-22-006882 001-37766 22882468 34 2042966
2022-04-14 4/A FORM 4/A SUBMISSION 0000899243-22-014838 7494
2022-03-07 4 FORM 4 SUBMISSION 0001209191-22-016851 7255
2022-03-07 3 FORM 3 SUBMISSION 0001209191-22-016848 10373
2022-03-04 4/A FORM 4/A SUBMISSION 0001209191-22-016539 5760
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016537 18228
2022-03-04 4/A FORM 4/A SUBMISSION 0001209191-22-016535 5792
2022-03-04 4/A FORM 4/A SUBMISSION 0001209191-22-016533 5791
2022-03-04 4/A FORM 4/A SUBMISSION 0001209191-22-016526 5808
2022-03-04 8-K 8-K 1.01,9.01 0001193125-22-066312 001-37766 22715219 34 409054 1 1
2022-03-04 424B5 424B5 0001193125-22-066277 333-251022 22715077 33 561338
2022-03-04 8-K 8-K 8.01 0001564590-22-008741 001-37766 22713971 34 167627 1 1
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015976 17554
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015960 13553
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015917 17235
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015909 12675
2022-02-28 8-K 8-K 7.01,8.01,9.01 0001193125-22-057945 001-37766 22690012 34 239216 1 1
2022-02-24 S-8 S-8 0001193125-22-052430 333-262997 22672782 33 57968
2022-02-24 10-K 10-K 0000950170-22-001981 001-37766 22671361 34 20023967 1 1
2022-02-24 8-K 8-K 2.02,9.01 0000950170-22-001865 001-37766 22666572 34 423342 1 1
2022-02-14 SC 13G/A SC13G/A 0001140361-22-005030 005-89486 22624452 34 63792
2022-02-11 SC 13G/A SCHEDULE 13G/A 0001104659-22-020472 005-89486 22620775 34 42921
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-017825 005-89486 22610034 34 12987
2022-02-09 SC 13G/A SC 13G/A 0001104659-22-016158 005-89486 22605923 34 40386
2022-02-09 SC 13G filing.txt 0000315066-22-001002 005-89486 22604289 34 8303
2022-02-04 SC 13G/A AMENDMENT NO. 5 0001214659-22-001845 005-89486 22590807 34 67338
2022-02-03 SC 13G/A us45826j1051_020322.txt 0000834237-22-006298 005-89486 22589121 34 13463
2022-02-03 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-22-026436 001-37766 22586574 34 191603 1 1
2022-01-06 8-K 8-K 2.02,9.01 0000950170-22-000098 001-37766 22513646 34 263622 1 1
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001651 7382
2021-12-29 3 FORM 3 SUBMISSION 0000899243-21-050029 7186
2021-11-26 SC 13G/A SCHEDULE 13G/A 0001104659-21-143942 005-89486 211451663 34 49991
2021-11-09 4 FORM 4 SUBMISSION 0001209191-21-063698 14927
2021-11-04 10-Q 10-Q 0000950170-21-003088 001-37766 211380486 34 10832951 1 1
2021-11-04 8-K 8-K 2.02,9.01 0000950170-21-002937 001-37766 211378048 34 395179 1 1
2021-10-15 4 FORM 4 SUBMISSION 0001209191-21-060638 17457
2021-10-13 4 FORM 4 SUBMISSION 0001209191-21-060359 8714
2021-10-07 4 FORM 4 SUBMISSION 0001209191-21-059960 20874
2021-09-27 4 FORM 4 SUBMISSION 0001209191-21-057778 7031
2021-09-23 4 FORM 4 SUBMISSION 0001209191-21-057475 12778
2021-09-09 4 FORM 4 SUBMISSION 0001209191-21-055347 9270
2021-09-01 4 FORM 4 SUBMISSION 0001209191-21-054331 45186
2021-09-01 4 FORM 4 SUBMISSION 0001209191-21-054321 29601
2021-09-01 4 FORM 4 SUBMISSION 0001209191-21-054317 17446
2021-09-01 4 FORM 4 SUBMISSION 0001209191-21-054315 33482
2021-08-25 4 FORM 4 SUBMISSION 0001209191-21-053305 13795
2021-08-20 4 FORM 4 SUBMISSION 0001209191-21-052835 14280
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050881 9031
2021-08-06 4 FORM 4 SUBMISSION 0001209191-21-050228 21383
2021-08-06 4 FORM 4 SUBMISSION 0001209191-21-050225 13341
2021-08-05 10-Q 10-Q 0001564590-21-041673 001-37766 211149093 34 9695314 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001564590-21-041189 001-37766 211146366 34 1953275 1 1
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045513 5445
2021-07-06 3 FORM 3 SUBMISSION 0001209191-21-045509 7062
2021-07-02 8-K 8-K 1.01,9.01 0001193125-21-207573 001-37766 211069842 34 490533 1 1
2021-07-01 424B5 424B5 0001193125-21-206461 333-251022 211066699 33 621128
2021-06-29 4 OWNERSHIP DOCUMENT 0001104659-21-086607 52247
2021-06-28 424B5 424B5 0001193125-21-201898 333-251022 211053303 33 617698
2021-06-28 8-K 8-K 7.01,8.01,9.01 0001193125-21-201044 001-37766 211049912 34 243511 1 1
2021-06-25 4 FORM 4 SUBMISSION 0001209191-21-043385 7238
2021-06-25 4 FORM 4 SUBMISSION 0001209191-21-043381 7244
2021-06-25 4 FORM 4 SUBMISSION 0001209191-21-043377 8949
2021-06-25 4 FORM 4 SUBMISSION 0001209191-21-043374 7306
2021-06-25 4 FORM 4 SUBMISSION 0001209191-21-043372 7228
2021-06-25 4 FORM 4 SUBMISSION 0001209191-21-043366 7250
2021-06-25 4 FORM 4 SUBMISSION 0001209191-21-043362 7229
2021-06-24 8-K 8-K 062421 5.07 0001564590-21-034323 001-37766 211043787 34 199200 1 1
2021-06-22 8-K 8-K 5.02,8.01,9.01 0001564590-21-033732 001-37766 211033051 34 230672 1 1
2021-06-17 8-K 8-K 1.01,8.01,9.01 0001564590-21-033357 001-37766 211024926 34 251745 1 1
2021-06-15 4 OWNERSHIP DOCUMENT 0001104659-21-081255 27957
2021-05-06 10-Q 10-Q 0001564590-21-024947 001-37766 21897721 34 8947212 1 1
2021-05-06 8-K 8-K 2.02,9.01 0001564590-21-024536 001-37766 21895836 34 484070 1 1
2021-04-30 4 OWNERSHIP DOCUMENT 0001104659-21-059347 15187
2021-04-28 4 OWNERSHIP DOCUMENT 0001104659-21-056726 26059
2021-04-28 DEFA14A DEFA14A 0001564590-21-021426 001-37766 21865082 34 522694
2021-04-28 DEF 14A DEF 14A 0001564590-21-021413 001-37766 21864886 34 3317950
2021-04-15 4 FORM 4 SUBMISSION 0001209191-21-026891 11824
2021-04-13 4 FORM 4 SUBMISSION 0001209191-21-026445 7301
2021-04-13 3 FORM 3 SUBMISSION 0001209191-21-026442 7030
2021-04-12 8-K 8-K GEORGIA KERESTY 5.02,9.01 0001564590-21-018399 001-37766 21819408 34 355550 1 1
2021-04-07 4 OWNERSHIP DOCUMENT 0001104659-21-047492 14666
2021-04-06 4 FORM 4 SUBMISSION 0001209191-21-025734 13241
2021-04-02 4 FORM 4 SUBMISSION 0001209191-21-024889 15190
2021-04-02 4 FORM 4 SUBMISSION 0001209191-21-024888 61901
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018327 8169
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018326 8160
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018324 8128
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018323 8236
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018322 8152
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018321 8153
2021-03-01 4 OWNERSHIP DOCUMENT 0001104659-21-029884 14483
2021-02-26 S-8 S-8 0001193125-21-058294 333-253562 21683656 33 47781
2021-02-26 10-K 10-K 0001564590-21-009011 001-37766 21682365 34 13549298 1 1
2021-02-25 8-K 8-K 2.02,9.01 0001564590-21-008436 001-37766 21676445 34 427852 1 1
2021-02-16 SC 13G/A SCHEDULE 13GA 0001104659-21-024176 005-89486 21639378 34 42544
2021-02-11 SC 13G/A SC 13G/A 0001140361-21-004349 005-89486 21620027 34 67985
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-018363 005-89486 21611026 34 13862
2021-02-09 4 FORM 4 SUBMISSION 0001209191-21-009085 9712
2021-02-09 4 FORM 4 SUBMISSION 0001209191-21-009083 19749
2021-02-05 SC 13G/A AMENDMENT NO. 4 0001214659-21-001374 005-89486 21593359 34 67240
2021-02-03 4 FORM 4 SUBMISSION 0001209191-21-007638 55014
2021-02-03 4 FORM 4 SUBMISSION 0001209191-21-007637 34386
2021-01-29 SC 13G/A us45826j1051_012921.txt 0000834237-21-003818 005-89486 21568637 34 13480
2021-01-22 SC 13D/A SC 13D/A 0001104659-21-006707 005-89486 21546577 34 169741
2021-01-22 4 FORM 4 SUBMISSION 0001209191-21-004866 6936
2021-01-07 8-K NTLA_8K_01072021 2.02,8.01,9.01 0001564590-21-000493 001-37766 21513008 34 253532 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (287 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 140.36M 2026-10-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
dei EntityPublicFloat Entity Public Float USD 869.49M 2025-06-30 2025 FY 10-K 2026-02-26 0001193125-26-076550
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.40M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001193125-26-197283
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.93M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001193125-26-197283
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 187.14 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001193125-26-197283
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 3.24M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001193125-26-197283
ecd PeoTotalCompAmt PeoTotalCompAmt USD 5.06M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001193125-26-197283
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 16.53 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001193125-26-197283
ffd NetFeeAmt NetFeeAmt USD 0 2026-11-20 S-3ASR 2026-11-20 0001193125-26-470525
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 207.00M 2026-04-29 424B5 2026-04-29 0001193125-26-192361
ffd TtlFeeAmt TtlFeeAmt USD 0 2026-11-20 S-3ASR 2026-11-20 0001193125-26-470525
ffd TtlOfferingAmt TtlOfferingAmt USD 368.50M 2026-11-20 S-3ASR 2026-11-20 0001193125-26-470525
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-20 S-3ASR 2026-11-20 0001193125-26-470525
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-20 S-3ASR 2026-11-20 0001193125-26-470525
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 12.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 7.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AccountsReceivableRelatedParties Accounts Receivable, Related Parties USD 0 2021-12-31 2022 Q3 10-Q 2022-11-03 0000950170-22-021835
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 300,000 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017866
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 5.30M 2019-09-30 2019 Q3 10-Q 2019-10-31 0001564590-19-039199
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 200,000 2015-09-30 2016 Q3 10-Q 2016-11-01 0001193125-16-755383
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 46.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 6.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 58.61M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 3.54B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 14.40M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 81,000 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062011
us-gaap AdministrativeFeePayable AdministrativeFeePayable USD 3.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 45.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 54,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 54,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 12.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AssetAcquisitionContingentConsiderationLiability AssetAcquisitionContingentConsiderationLiability USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029007
us-gaap Assets Assets USD 902.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AssetsCurrent Assets, Current USD 506.35M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 330.90M 2017-12-31 2017 FY 10-K 2018-03-14 0001564590-18-005544
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 41,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 2.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 461.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 458.71M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 56.11M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018736
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018736
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 153,000 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018736
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 287,000 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018736
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 321,000 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018736
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 57,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-337952
us-gaap CapitalizedContractCostGross Capitalized Contract Cost, Gross USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 156.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 330.90M 2017-12-31 2017 FY 10-K 2018-03-14 0001564590-18-005544
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -11.76M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-02 0001564590-19-015384
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 171.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 3.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 240.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 140.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 140.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap CommonStockValue Common Stock, Value, Issued USD 14,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -333.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ContingentConsiderationClassifiedAsEquityFairValueDisclosure Contingent Consideration Classified as Equity, Fair Value Disclosure USD 100,000 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029007
us-gaap ContractRevenueCost Contract Revenue Cost (Deprecated 2018-01-31) USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-01 0001564590-18-009946
us-gaap ContractualObligation Contractual Obligation USD 0 2017-12-31 2017 FY 10-K 2018-03-14 0001564590-18-005544
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized USD -7.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 7.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 88.56M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004680
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001981
us-gaap CostsAndExpenses Costs and Expenses USD 365.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 5.43M 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004680
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 75.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 29.92M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 15.68M 2018-06-30 2018 Q2 10-Q 2018-08-01 0001564590-18-018256
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 35.18M 2018-06-30 2018 Q2 10-Q 2018-08-01 0001564590-18-018256
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 1.56M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxAssetsEquityMethodInvestments Deferred Tax Assets, Equity Method Investments USD 14.74M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 944.56M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 773,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 29.92M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 457.01M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 1.67B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 236.80M 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007409
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 243.72M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 26.04M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 5.64M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 914.64M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 405.30M 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029007
us-gaap DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals USD 1.03M 2016-12-31 2016 FY 10-K 2017-03-14 0001193125-17-082186
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 968,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap DeferredTaxLiabilitiesTaxDeferredIncome Deferred Tax Liabilities, Tax Deferred Income USD 811,000 2015-12-31 2016 FY 10-K 2017-03-14 0001193125-17-082186
us-gaap Depreciation Depreciation USD 3.00M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001564590-18-005544
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 6.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 700,000 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017866
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 1.60M 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004097
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.53 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.96 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007805
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.53 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.251 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.187 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007409
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.001 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029007
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.045 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.079 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.023 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 20.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 27.10M 2021-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001981
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 56.10M 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018736
us-gaap EquityMethodInvestmentDeferredGainOnSale Equity Method Investment, Deferred Gain on Sale USD 2.94M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001981
us-gaap EquityMethodInvestments Equity Method Investments USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029007
us-gaap EquityMethodInvestmentSoldCarryingAmount Equity Method Investment, Amount Sold USD 6.62M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018736
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD -24.13M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029007
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029007
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269680
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -10.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 68,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 118.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -67.54M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001564590-18-005544
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap IncomeTaxEffectsAllocatedDirectlyToEquity Income Tax Effects Allocated Directly to Equity USD 1.00M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-14 0001564590-18-005544
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap IncomeTaxExpenseBenefitIntraperiodTaxAllocation Income Tax Expense (Benefit), Intraperiod Tax Allocation USD -1.01M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-14 0001564590-18-005544
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 103.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -86.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 18.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 666,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -9.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -9.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -1.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -3.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -7.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -9.01M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-01 0001564590-18-018256
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 400,000 2020-09-01 2020-09-30 2021 FY 10-K 2022-02-24 0000950170-22-001981
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -155,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-26 0001564590-21-009011
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -494,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 11.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap InterestAndOtherIncome Interest and Other Income USD 16.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap InterestExpense Interest Expense USD 611,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap InterestExpenseDebt Interest Expense, Debt USD 611,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 557,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 557,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 11.00M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-337952
us-gaap InvestmentsAndOtherNoncurrentAssets Investments and Other Noncurrent Assets USD 29.11M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure USD 7.98M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions Investments in and Advances to Affiliates, at Fair Value, Gross Reductions USD 9.50M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021835
us-gaap LeaseCost Lease, Cost USD 48.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.08 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004097
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 270.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 157.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 32.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 13.04M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 27.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 26.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 25.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 2.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 114.34M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap Liabilities Liabilities USD 289.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 902.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap LiabilitiesCurrent Liabilities, Current USD 80.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 7.47M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-01 0001564590-18-009946
us-gaap LongTermDebt Long-term Debt USD 73.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 73.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap MarketableSecurities Marketable Securities USD 249.49M 2019-03-31 2019 Q1 10-Q 2019-05-02 0001564590-19-015384
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 318.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 140.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057046
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -3.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 303.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 6.72M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-01 0001564590-18-009946
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -13.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -1.85M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-01 0001564590-18-009946
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -285.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -17.77M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-01 0001564590-18-009946
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -330.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap OciEquityMethodInvestmentAfterTaxParent OciEquityMethodInvestmentAfterTaxParent USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -335.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap OperatingLeaseCost Operating Lease, Cost USD 42.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 156.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 20.98M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 135.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap OperatingLeasePayments Operating Lease, Payments USD 63.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 212.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 2.52M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 32.98M 2016-09-30 2016 Q3 10-Q 2016-11-01 0001193125-16-755383
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 4.89M 2016-09-30 2016 Q3 10-Q 2016-11-01 0001193125-16-755383
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 4.75M 2016-09-30 2016 Q3 10-Q 2016-11-01 0001193125-16-755383
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 4.61M 2016-09-30 2016 Q3 10-Q 2016-11-01 0001193125-16-755383
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 4.47M 2016-09-30 2016 Q3 10-Q 2016-11-01 0001193125-16-755383
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 9.37M 2016-09-30 2016 Q3 10-Q 2016-11-01 0001193125-16-755383
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 4.89M 2016-09-30 2016 Q3 10-Q 2016-11-01 0001193125-16-755383
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.075 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 6.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 5.17M 2021-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003088
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -1.53M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -3.19M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004097
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAociForInvestmentTransferredFromAvailableForSaleToEquityMethodTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Investment Transferred from Available-for-sale to Equity Method, Tax USD 2.13M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1.64M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004097
us-gaap OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent Other Employee-related Liabilities USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap OtherInvestments Other Investments USD 3.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 10.79M 2022-06-30 2022 Q2 10-Q 2022-08-04 0000950170-22-014731
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 5.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 301,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 424,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004680
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 287,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029007
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029007
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 321.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 2.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 24.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 2.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap PrepaidRent Prepaid Rent USD 899,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 73.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-04 0000950170-22-014731
us-gaap ProceedsFromIssuanceOfCommonLimitedPartnersUnits Proceeds from Issuance of Common Limited Partners Units USD 349,000 2014-05-07 2014-12-31 2016 FY 10-K 2017-03-14 0001193125-17-082186
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 194.60M 2026-04-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 85.00M 2015-05-06 2021-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003088
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 310.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 357,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 16,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 1.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -330.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 76.28M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 13.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD 2.13M 2024-01-01 2024-03-31 2024 Q3 10-Q 2024-11-07 0000950170-24-123276
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 246.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017866
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 15.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.27 2025-01-01 2025-01-31 2025 Q3 10-Q 2025-11-06 0001193125-25-269680
us-gaap RestructuringCharges Restructuring Charges USD 6.50M 2025-01-01 2025-03-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -2.92B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 29.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 6.60M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018736
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 4.93M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017866
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 82.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 45.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 90,462 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001564590-18-005544
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 1.34 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001564590-18-005544
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 3.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 14.43 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 6.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 17.4 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 1.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 23.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.836 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.44M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 42.92 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 7.60M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018736
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 547,529 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-10-31 0001564590-18-025733
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 16.55 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-10-31 0001564590-18-025733
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 296,607 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 824,581 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 28.92 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018736
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 36.57 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 13.4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 32.52 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 13.68 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 10.75 2026-04-28 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004097
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 613.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 30,897 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004097
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 16.74M 2026-04-28 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1,250 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.52M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 45.26M 2021-01-01 2021-03-31 2021 Q2 10-Q 2021-08-05 0001564590-21-041673
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 16,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap SubleaseIncome Sublease Income USD 1.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap TemporaryEquityAccretionOfInterest Temporary Equity, Accretion of Interest USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001193125-17-082186
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 88.56M 2015-12-31 2016 FY 10-K 2017-03-14 0001193125-17-082186
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap VariableLeaseCost Variable Lease, Cost USD 7.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076550
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 130.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 74.75M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007805
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 130.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449862

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →